[Figure, Figure 1: The In vivo Model Assay Development Cycle.] - Assay Guidance Manual

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Markossian S, Grossman A, Arkin M, et al., editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-.

Assay Guidance Manual [Internet].

Show details

Contents

Figure 1: The In vivo Model Assay Development Cycle.

From: In Vivo Assay Guidelines

All Assay Guidance Manual content, except where otherwise noted, is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported license (CC BY-NC-SA 3.0), which permits copying, distribution, transmission, and adaptation of the work, provided the original work is properly cited and not used for commercial purposes. Any altered, transformed, or adapted form of the work may only be distributed under the same or similar license to this one.

Contents

Views

Cite this Page
Haas J, Manro J, Shannon H, et al. In Vivo Assay Guidelines. 2012 May 1 [Updated 2012 Oct 1]. In: Markossian S, Grossman A, Arkin M, et al., editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-. [Figure, Figure 1: The In vivo Model Assay Development Cycle.]
PDF version of this page (1.1M)
PDF version of this title (79M)

Assay Guidance Manual Links

New in Assay Guidance Manual

Related information

PMC
PubMed Central citations
PubMed
Links to PubMed

Similar articles in PubMed

Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.[Cochrane Database Syst Rev. 2022]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, et al. Cochrane Database Syst Rev. 2022 Feb 1; 2(2022). Epub 2022 Feb 1.
In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test.[Mutat Res. 2007]
In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test.
Hayashi M, MacGregor JT, Gatehouse DG, Blakey DH, Dertinger SD, Abramsson-Zetterberg L, Krishna G, Morita T, Russo A, Asano N, et al. Mutat Res. 2007 Feb 3; 627(1):10-30. Epub 2006 Dec 6.
Review Assay Guidance Manual[ 2004]
Review Assay Guidance Manual
Markossian S, Grossman A, Arkin M, Auld D, Austin C, Baell J, Brimacombe K, Chung TDY, Coussens NP, Dahlin JL, et al. 2004
Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.[J Pharm Biomed Anal. 2011]
Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
Valentin MA, Ma S, Zhao A, Legay F, Avrameas A. J Pharm Biomed Anal. 2011 Jul 15; 55(5):869-77. Epub 2011 Mar 29.
Review Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring.[Ther Drug Monit. 2019]
Review Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring.
Capiau S, Veenhof H, Koster RA, Bergqvist Y, Boettcher M, Halmingh O, Keevil BG, Koch BCP, Linden R, Pistos C, et al. Ther Drug Monit. 2019 Aug; 41(4):409-430.

See reviews...See all...

Recent Activity

Clear Turn Off Turn On

[Figure, Figure 1: The In vivo Model Assay Development Cycle.] - Assay Guidance ...
[Figure, Figure 1: The In vivo Model Assay Development Cycle.] - Assay Guidance Manual

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on